Endo Ventures Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ENDO VENTURES LTD, and what generic alternatives to ENDO VENTURES LTD drugs are available?
ENDO VENTURES LTD has one approved drug.
There are three US patents protecting ENDO VENTURES LTD drugs.
There are fourteen patent family members on ENDO VENTURES LTD drugs in eight countries.
Summary for Endo Ventures Ltd
International Patents: | 14 |
US Patents: | 3 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Endo Ventures Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | DISCN | Yes | No | 8,287,489 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | DISCN | Yes | No | 7,901,385 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | DISCN | Yes | No | 7,776,007 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-002 | Nov 26, 2013 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Endo Ventures Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | 8,241,243 | ⤷ Try a Trial |
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | 6,681,810 | ⤷ Try a Trial |
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | 6,135,979 | ⤷ Try a Trial |
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | 6,174,304 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Endo Ventures Ltd Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
United Kingdom | 0206560 | ⤷ Try a Trial |
Germany | 60315429 | ⤷ Try a Trial |
Japan | 2007512929 | ⤷ Try a Trial |
Japan | 4610567 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.